The Kaplan–Meier (K-M) survival curves suggested that higher ANKRD1 expression was correlated with better OS in DLBC, LGG, and THYM, but with lower OS in BLCA, CESC, COAD, GBM, HNSC, kidney renal clear cell carcinoma (KIRC), KIRP, LIHC, LUSC, MESO, PAAD, and STAD (P < 0.05) (Fig. 2B–P). Here, ANKRD1 is linked to bladder transitional cell carcinoma.